With the release of the latest recommendations from EULAR our expert panel, Dr. Sheetal Desai, Dr. Alfred Kim, and Dr. Donald Thomas, will hold a lively and interactive discussion about how this recently updated guidance on the earlier use of biologics can be adopted into routine clinical practice. This will include a discussion on how early intervention can help to achieve short-term and long-term treatment objectives in SLE, as well as examining the barriers that need to be overcome to support earlier treatment. Participate in our conversation on the earlier use of biologics, with the goal of improving outcomes for patients with lupus. Developed and offered by GSK.
Non-CME